Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment ceased in phase III NSCLC study of Sarasar

Feb. 10, 2004

Novel steroid sulphate inhibitor for breast tumor therapy reported

Feb. 10, 2004

AP-5346 makes preclinical and clinical progress

Feb. 9, 2004

Alimta approved for use with cisplatin for malignant pleural mesothelioma

Feb. 9, 2004

Orphan drug status for BCX-1777 for T-cell non-Hodgkin's lymphoma

Feb. 9, 2004

DepoCyte launched in Europe

Feb. 9, 2004

French team reports novel proapoptitic and antiangiogenic agents for cancer therapy

Feb. 9, 2004

Abbott and Caprion collaborate on drug discovery for lung cancer

Feb. 9, 2004

Phase I ThermoDox protocol amendments allowed

Feb. 6, 2004

IP3R3 involved in peritoneal metastasis of gastric cancers

Feb. 6, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...